William Blair lifted their Q1 2026 earnings estimates for shares of Ionis Pharmaceuticals in a research note issued on ...

William Blair analyst Myles Minter reiterated a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today. The company’s shares opened ...

Arizona State Retirement System raised its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 8.8% in the ...

Ionis Pharmaceuticals IONS announced that the European Commission (“EC”) has approved Wainzua (eplontersen) for treating ...

Ionis Pharmaceuticals (IONS) and Ono Pharmaceutical announced that the two companies have entered into a license agreement in which Ono obtains ...

Much of cell behavior is governed by the actions of biomolecular condensates: building block molecules that glom together and ...

Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical applications.

The use of glycine in a neutral solution enhances lithium extraction from spent batteries, offering a sustainable alternative ...